Alcon Inc.
NYSE:ALCMedical - Instruments & Supplies
+$0.61 today
- Market cap
- $36.15B
- Beta
- 0.70
- P/E (TTM)
- 38.7
- EPS (TTM)
- $1.67
- Dividend yield
- 0.55%
Volume 4.74M
Average 1.91M
ALC EBITDA Margin
EBITDA as a percentage of revenue.
Alcon Inc.NYSE: ALC
EBITDA Margin · Q3 FY2026 · quarter ended Sep 2026
EBITDA Margin narrows to 24.7%
EBITDA Margin was 24.7% in Q3 FY2026, down 0.7 pp from a year earlier. On a trailing-twelve-month basis it was 25.4%, down 0.9 pp year over year. Over 3 fiscal years it widened by 4.0 pp.
Context
- EBITDA Margin widened in 2 of the last 3 fiscal years.
What to watch
Whether EBITDA Margin reaches the consensus estimate from 12 analysts of 31.7% for the fiscal year ending Dec 2026, up from 24.0% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- 24.7%-3.6 pp QoQ
- Last fiscal yearDec 2025
- 24.0%-3.0 pp YoY
- LTMSep 2026
- 25.4%-0.9 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -0.7 pp | -0.0 pp | +0.7 pp |
| 1 year | -3.0 pp | +7.7 pp | +10.7 pp |
| 3 years | +4.0 pp | +8.0 pp | +3.9 pp |
| 5 years | +9.5 pp | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 24.0%
- Year-over-year change
- -3.0pp
| Period | Period end | EBITDA Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 24.0% | -3.0pp |
| FY2024 | 2024-12-31 | 27.0% | +3.3pp |
| FY2023 | 2023-12-31 | 23.7% | +3.8pp |
| FY2022 | 2022-12-31 | 20.0% | -1.2pp |
| FY2021 | 2021-12-31 | 21.2% | — |
EBITDA Margin vs competitors
How ALC compares with its peers on the latest reported figures
- ALC's LTM Sep 2026 EBITDA Margin of 25.4% is the 2nd highest of the 8 companies compared; the peer median is -1.4%.
- Its year-over-year change of -0.9 pp is the 5th highest of 8, against a peer median of +4.5 pp.
- Over three fiscal years its change of +4.0 pp compares with a peer median of -4.3 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Mar 2026 | 58.8% | +150.4 pp | -4.3 pp | |
| LTM Sep 2026 | 25.4% | -0.9 pp | +4.0 pp | |
| LTM Jul 2026 | 21.5% | -5.5 pp | -0.8 pp | |
| LTM Jun 2026 | 13.9% | +4.5 pp | -5.4 pp | |
| LTM Apr 2026 | -1.4% | +10.6 pp | -48.3 pp | |
| LTM Jun 2026 | -23.0% | -12.0 pp | -11.5 pp | |
| LTM Mar 2026 | -33.9% | -19.3 pp | +89.0 pp | |
| LTM Mar 2026 | -39.8% | +16.3 pp | +70.4 pp | |
| Peer median (excluding ALC) | -1.4% | +4.5 pp | -4.3 pp | |
Competitors are the stored peer set for ALC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 8.29B | 8.72B | 9.46B | 9.91B | 10.4B |
| Cost of Revenue | 3.64B | 3.97B | 4.21B | 4.4B | 4.66B |
| Gross Profit | 4.65B | 4.75B | 5.25B | 5.51B | 5.75B |
| Gross Margin | 56.1% | 54.5% | 55.5% | 55.6% | 55.2% |
| Research & Development | 842M | 702M | 859M | 876M | 990M |
| Selling, General & Admin | 3.08B | 3.07B | 3.21B | 3.25B | 3.45B |
| Operating Expenses | 4.07B | 4.08B | 4.21B | 4.1B | 4.39B |
| Depreciation & Amortization | 1.22B | 1.12B | 1.22B | 1.23B | 1.34B |
| EBITDA | 1.76B | 1.74B | 2.24B | 2.68B | 2.5B |
| EBITDA Margin | 21.2% | 20.0% | 23.7% | 27.0% | 24.0% |
| Operating Income | 580M | 672M | 1.04B | 1.41B | 1.36B |
| Operating Margin | 7.0% | 7.7% | 11.0% | 14.3% | 13.1% |
| Interest Income | 3.01M | 16.52M | 34M | 81.45M | 74M |
| Interest Expense | 120.26M | 138.4M | 189M | 186.18M | 204M |
| Other Income / Expenses | (162M) | (209M) | (207M) | (157M) | (200M) |
| Income Before Tax | 418M | 463M | 832M | 1.26B | 1.16B |
| Pre-Tax Margin | 5.0% | 5.3% | 8.8% | 12.7% | 11.2% |
| Income Tax Expense | 42M | 128M | (142M) | 238M | 180M |
| Net Income | 376M | 335M | 974M | 1.02B | 980M |
| Net Margin | 4.5% | 3.8% | 10.3% | 10.3% | 9.4% |
| EPS (Basic) | 0.77 | 0.68 | 1.98 | 2.06 | 1.99 |
| EPS (Diluted) | 0.76 | 0.68 | 1.96 | 2.05 | 1.98 |
| Weighted Avg Shares | 490M | 491.4M | 493M | 494.4M | 494.95M |
| Weighted Avg Shares (Diluted) | 493.4M | 494.4M | 496.5M | 497.5M | 496.2M |
Alcon Inc.
NYSE:ALC
Intrinsic Alpha fair value
Locked
Current Price
$75.26
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.